Consonance-HFW Acquisition Corp. (CHFW) to Combine with Surrozen in $203M Deal

Consonance-HFW Acquisition Corp. (CHFW) to Combine with Surrozen in $203M Deal

Consonance-HFW (NYSE:CHFW) has entered into a definitive agreement to combine with biotech firm Surrozen at an enterprise value of $203.3 million. San Francisco-based Surrozen is developing preclinical drugs to combat bowel and liver disorders using therapies targeting Wnt-pathways. The combined company is expected to list on the Nasdaq under the symbol “SRZN” once the deal
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.